Advertisement
Australia markets closed
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • AUD/USD

    0.6525
    -0.0010 (-0.16%)
     
  • OIL

    82.65
    +1.30 (+1.60%)
     
  • GOLD

    2,237.10
    +24.40 (+1.10%)
     
  • Bitcoin AUD

    108,762.10
    +2,803.53 (+2.65%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6039
    +0.0008 (+0.14%)
     
  • AUD/NZD

    1.0903
    +0.0023 (+0.21%)
     
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NASDAQ

    18,257.50
    -23.34 (-0.13%)
     
  • FTSE

    7,961.91
    +29.93 (+0.38%)
     
  • Dow Jones

    39,765.39
    +5.31 (+0.01%)
     
  • DAX

    18,493.65
    +16.56 (+0.09%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     

Novel Vaccine Delivery System Market to Reach $14.43 Billion by 2030: Allied Market Research

Rise in government support and investment, development of novel vaccines, and growth in immunization programs & their increasing coverage drive the growth of the global novel vaccine delivery systems market. The market across North America held the lion’s share in 2020, accounting for more than one-third of the market. The Covid-19 pandemic severely disrupted the workflow in the healthcare industry. The outbreak forced several industries to shut down temporarily.

Portland, OR, July 30, 2021 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global Novel Vaccine Delivery System Market was accounted for $5.03 billion in 2020, and is estimated to reach $14.43 billion by 2030, growing at a CAGR of 10.8% from 2021 to 2030.

Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/12149

Rise in government support and investment, development of novel vaccines, and growth in immunization programs & their increasing coverage drive the growth of the global novel vaccine delivery systems market. However, high cost and unaffordability of safety syringes and alternative modes of drug delivery hinder the market growth. On the contrary, FDA approval to Covid-19 vaccine and increase in need for safety syringes in emerging economies would open new opportunities for the market players in the coming years.

ADVERTISEMENT

Covid-19 scenario:

  • The Covid-19 pandemic severely disrupted the workflow in the healthcare industry. The outbreak forced several industries to shut down temporarily.

  • However, the surge in demand for various medical services including novel vaccine delivery products increased during the pandemic. As the medical disposables including needles and syringes were in demand, several governments announced contracts to increase in manufacturing and supply of needs and syringes across the world.

The report divides the global novel vaccine delivery system market on the basis of delivery mode, device, and region.

Based on delivery mode, the intramuscular segment held the largest share in 2020, accounting for nearly two-thirds of the market. However, the subcutaneous segment is projected to manifest the highest CAGR of 12.3% during the forecast period.

Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/12149

On the basis of device, the syringe segment held the lion’s share in 2020, contributing to more than half of the market. However, the needle-free injections segment is estimated to portray the highest CAGR of 11.3% from 2021 to 2030.

The global novel vaccine delivery system market is analyzed across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America held the lion’s share in 2020, accounting for more than one-third of the market. However, the market across Asia-Pacific is anticipated to showcase the highest CAGR of 12.4% during the forecast period.

The global novel vaccine delivery system market includes an in-depth analysis of the prime market players such as Becton, Dickinson, and Company, Altaris Capital Partners, LLC (Kindeva Drug Delivery), Gerresheimer AG, Carl Zeiss Foundation (Schott AG), Inovio Pharmaceuticals, Inc. (Bioject Medical Technologies), Gurnet Point Capital (Corium International Inc.), Retractable Technologies, Inc., PharmaJet, Inc., Terumo Corporation, and VAXXAS Pty Ltd.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.

Similar Reports:

Medical Thawing System Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Spirometer Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

OTC Braces and Supports Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Gloves market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Breast Cancer Liquid Biopsy Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Heparin Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Anti-viral Therapies Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

CONTACT: Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research